Cittadine Andrew
Chief Operating Officer
Officer
Latest Insider Transactions
9 transactions (past 365 days)
| 2026-10-02 | 2026-09-30 | MNPR Monopar Therapeutics | COO | Tax Payment | 1,944 | $79.67 | $154,878 |
| 2026-10-02 | 2026-09-30 | MNPR Monopar Therapeutics | COO | Exercise Conversion | 4,384 | $0.00 | $0 |
| 2026-07-02 | 2026-06-30 | MNPR Monopar Therapeutics | COO | Tax Payment | 2,309 | $92.59 | $213,790 |
| 2026-07-02 | 2026-06-30 | MNPR Monopar Therapeutics | COO | Exercise Conversion | 5,254 | $0.00 | $0 |
| 2026-04-02 | 2026-03-31 | MNPR Monopar Therapeutics | COO | Tax Payment | 1,571 | $54.79 | $86,075 |
| 2026-04-02 | 2026-03-31 | MNPR Monopar Therapeutics | COO | Exercise Conversion | 3,514 | $0.00 | $0 |
| 2026-01-05 | 2025-12-31 | MNPR Monopar Therapeutics | COO | Exercise Conversion | 4,326 | $0.00 | $0 |
| 2026-01-05 | 2025-12-31 | MNPR Monopar Therapeutics | COO | Tax Payment | 1,889 | $65.30 | -$123,352 |
| 2025-12-08 | 2025-12-02 | MNPR Monopar Therapeutics | COO | Award | 8,969 | $0.00 | $0 |
MNPR
COO
Exercise Conversion
$0
4,384 shares @ $0.00
Filed 2026-10-02Trade 2026-09-30
Monopar TherapeuticsMNPR
COO
Exercise Conversion
$0
5,254 shares @ $0.00
Filed 2026-07-02Trade 2026-06-30
Monopar TherapeuticsMNPR
COO
Exercise Conversion
$0
3,514 shares @ $0.00
Filed 2026-04-02Trade 2026-03-31
Monopar TherapeuticsMNPR
COO
Exercise Conversion
$0
4,326 shares @ $0.00
Filed 2026-01-05Trade 2025-12-31
Monopar Therapeutics